Hidradenitis Suppurativa

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2011-05-09
Clinical Trial Update: Study of Adalimumab in Subjects With Moderate to Severe Chronic Hidradenitis Suppurativa [Phase 2]
Phase 2 clinical trial evaluating adalimumab in adults with moderate to severe chronic hidradenitis suppurativa reported results. Results we…
CLINICAL_TRIALS trial_result · 2011-01-14
Clinical Trial Update: Etanercept for Treatment of Hidradenitis [Phase 2]
Phase 2 clinical trial update evaluating etanercept for hidradenitis suppurativa has completed. Results have been posted.
FDA approval · 2010-07-29
FDA Approved: HUMIRA — Supplemental Application (Cordavis Limited)
The FDA has approved a supplemental application for HUMIRA (adalimumab) filed by Cordavis Limited.
CLINICAL_TRIALS trial_result · 2009-01-23
Clinical Trial Update: To Assess the Efficacy and Safety of Adalimumab in Subjects With Moderate to Severe Hidradenitis Suppurativa [Phase 2]
Phase 2 trial evaluating the efficacy and safety of Humira (adalimumab) in subjects with moderate to severe hidradenitis suppurativa has com…
CLINICAL_TRIALS trial_result · 2008-11-24
Clinical Trial Update: Study to Assess the Safety and Efficacy of Infliximab to Treat Hidradenitis Suppurtativa [Phase 2]
Phase 2 study evaluating safety and efficacy of infliximab for hidradenitis suppurativa has completed.
Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
CLINICAL_TRIALS trial_result · 2007-10-10
Clinical Trial Update: A Small Clinical Study: Photodynamic Therapy to Treat Hidradenitis Suppurativa [NA]
The document reports a completed small clinical trial studying photodynamic therapy for hidradenitis suppurativa; no efficacy results are pr…
FDA approval · 2007-07-30
FDA Approved: HUMIRA — Supplemental Application (Cordavis Limited)
The FDA approved a supplemental application for Humira (adalimumab) submitted by Cordavis Limited.
CLINICAL_TRIALS trial_result · 2006-09-11
Clinical Trial Update: Efficacy and Safety of Efalizumab in the Treatment of Moderate-Severe Hydradenitis Suppurativa [Phase 1]
Phase 1 trial update showing the efficacy and safety of efalizumab in moderate-to-severe hidradenitis suppurativa, with the study sponsored …
FDA approval · 2006-07-28
FDA Approved: HUMIRA — Supplemental Application (Cordavis Limited)
FDA approved a supplemental application for Humira (adalimumab) submitted by Cordavis Limited, likely to authorize a new contract manufactur…
CLINICAL_TRIALS trial_result · 2006-05-25
Clinical Trial Update: Etanercept in Hidradenitis Suppurativa [Phase 2]
Phase 2 clinical trial of etanercept for hidradenitis suppurativa has completed.